Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
QTRX Quanterix Corp
- Stocks
- Healthcare
- NASDAQ: QTRX
Price (delayed)
$4.87
Market cap
$189.1M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.24
Enterprise value
$146.36M
Quanterix is a company that's digitizing biomarker analysis with the goal of advancing the science of precision health. The company's digital health solution, Simoa, has the potential to change the
Highlights
The debt has contracted by 10% YoY and by 2.6% from the previous quarter
The revenue has grown by 8% year-on-year
The gross profit rose by 5% year-on-year but it has declined by 2.6% since the previous quarter
QTRX's net income is down by 48% year-on-year and by 24% since the previous quarter
Quanterix's EPS has decreased by 46% YoY and by 24% QoQ
Key stats
What are the main financial stats of QTRX
Market
Valuations
Earnings
Shares outstanding
38.83M
Market cap
$189.1M
Enterprise value
$146.36M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.6
Price to sales (P/S)
1.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.08
Revenue
$135.69M
Gross profit
$80.97M
Operating income
-$63.83M
Net income
-$47.87M
EBIT
-$50.53M
EBITDA
-$41.43M
Free cash flow
-$33.01M
Per share
Balance sheet
Liquidity
EPS
-$1.24
EPS diluted
-$1.24
Free cash flow per share
-$0.85
Book value per share
$8.16
Revenue per share
$3.5
TBVPS
$9.64
Total assets
$396.51M
Total liabilities
$80.12M
Debt
$36.41M
Equity
$316.39M
Working capital
$294.61M
Debt to equity
0.12
Current ratio
8.29
Quick ratio
7.37
Net debt/EBITDA
1.03
Margins
Efficiency
Dividend
EBITDA margin
-30.5%
Gross margin
59.7%
Net margin
-35.3%
Operating margin
-47%
Return on assets
-11.7%
Return on equity
-14.4%
Return on invested capital
-14.8%
Return on capital employed
-14.2%
Return on sales
-37.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
QTRX stock price
How has the Quanterix stock price performed over time
Intraday
1.67%
1 week
-15.01%
1 month
-5.44%
1 year
-71.91%
YTD
-54.19%
QTD
-25.19%
Financial performance
How have Quanterix's revenue and profit performed over time
Revenue
$135.69M
Gross profit
$80.97M
Operating income
-$63.83M
Net income
-$47.87M
Gross margin
59.7%
Net margin
-35.3%
QTRX's net income is down by 48% year-on-year and by 24% since the previous quarter
The net margin has contracted by 38% YoY and by 26% from the previous quarter
The operating income has declined by 26% year-on-year and by 21% since the previous quarter
Quanterix's operating margin has decreased by 23% QoQ and by 17% YoY
Price vs fundamentals
How does QTRX's price correlate with its fundamentals
Growth
What is Quanterix's growth rate over time
Valuation
What is Quanterix stock price valuation
P/E
N/A
P/B
0.6
P/S
1.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.08
Quanterix's EPS has decreased by 46% YoY and by 24% QoQ
The price to book (P/B) is 79% lower than the 5-year quarterly average of 2.9 and 50% lower than the last 4 quarters average of 1.2
The equity has contracted by 8% YoY and by 4.1% from the previous quarter
QTRX's price to sales (P/S) is 85% less than its 5-year quarterly average of 9.2 and 55% less than its last 4 quarters average of 3.1
The revenue has grown by 8% year-on-year
Efficiency
How efficient is Quanterix business performance
QTRX's ROE has shrunk by 57% YoY and by 26% QoQ
The company's return on assets has shrunk by 54% YoY and by 24% QoQ
Quanterix's return on sales has decreased by 49% YoY and by 34% QoQ
The return on invested capital has declined by 41% since the previous quarter and by 11% year-on-year
Dividends
What is QTRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for QTRX.
Financial health
How did Quanterix financials performed over time
QTRX's quick ratio is down by 28% year-on-year and by 4.4% since the previous quarter
The current ratio is down by 27% year-on-year and by 4.3% since the previous quarter
The debt is 88% less than the equity
The debt has contracted by 10% YoY and by 2.6% from the previous quarter
The debt to equity is up by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.